Kyo026

PMCB

做空
Kyo026 已更新   
NASDAQ:PMCB   PharmaCyte Biotech, Inc.
1Y
RSI is falling.
MFI is in a decline.

5Y
RSI is oversold.
MFI has topped and falling.

ALL
RSI is reaching oversold.
MFI is at a bottom.

Prediction: This has another drop and once the RSI has bottomed on some of the timeframes it should be ready to fill the gap up around $8.

For my educational purpose, not to be used as financial advice.
评论:
Position taken.
评论:
Sold 4% gain.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。